Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2026-02-04 @ 12:29 PM
Study NCT ID:
NCT00566995
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2007-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Vandetanib in Individuals With Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-01
First Submit QC Date:
None
Study First Post Date:
2007-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-12
Results First Submit QC Date:
None
Results First Post Date:
2015-03-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-02
Last Update Post Date:
2018-10-30
Last Update Post Date Type:
ACTUAL